X

Analysis

SBFC Finance Reports 34% Increase in Q3 Net Profit to ₹118 Crore

SBFC Finance Ltd (NSE: SBFC) reported a 34% year-on-year (YoY) rise in profit after tax for the third quarter ended…

India Cements Ltd Competitive Position in the Indian Cement Sector

India Cements Ltd., (NSE:INDIACEM), a subsidiary of UltraTech Cement Limited, stands as a prominent regional leader in South India undergoing…

India Cements Ltd Q3 FY26 Resilient 25% Volume Growth and Operational Turnaround Amidst Strategic Restructuring

India Cements Ltd., (NSE:INDIACEM), a subsidiary of UltraTech Cement Limited, is a major player in the Indian building materials sector…

JTL Industries Reports 6.2% Rise in Q3 Net Profit as Operational Margins Expand

JTL Industries Ltd (NSE: JTLIND; BSE: 534600) reported its third-quarter financial results for the 2026 fiscal year following a board…

D. P. Abhushan Q3 FY2026 Results Show Strong Revenue and Profit Growth

D. P. Abhushan Limited (NSE: DPABHUSHAN, BSE: 544161) reported its financial results for the third quarter of fiscal year 2026,…

UltraTech Cement Q3 profit beats estimates on robust infrastructure demand

UltraTech Cement Ltd (NSE: ULTRACEMCO) reported a 27% increase in consolidated net profit for the December quarter, surpassing analyst expectations…

UltraTech Cement Reports 23% Revenue Growth in Q3 FY26 as Capacity Reaches 194 MTPA

Growth Accelerates with Scale Advantage Aditya Birla Group's flagship cement producer recorded consolidated net sales of ₹21,506 crore and improved…

D.P. Abhushan Limited: Strategic Resilience and Profitability in a Dynamic Jewelry Market

In an era where the Indian jewelry sector is navigating the twin challenges of record-high gold prices and shifting consumer…

D.P. Abhushan Limited: Scaling New Heights Amidst Market Volatility

D.P. Abhushan Limited (NSE: DPABHUSHAN), a premier name in the Indian retail jewelry sector, has once again demonstrated its operational…

OneSource Specialty Pharma Ltd operational scale expands amid near-term earnings volatility

OneSource Specialty Pharma Ltd (BSE: 544292 / NSE: ONESOURCE) has emerged as a multi-modality contract development and manufacturing organisation (CDMO)…